During the past decade, Groupe Hospitalier Diaconesses Croix Saint Simon conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 4 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 2 clinical trials were completed. i.e. 4.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Groupe Hospitalier Diaconesses Croix Saint Simon" #1 sponsor was "ARCAGY/ GINECO GROUP" with 14 trials, followed by "Groupe Hospitalier Diaconesses Croix Saint-Simon" with 11 trials sponsored, "UNICANCER" with 7 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe Hospitalier Diaconesses Croix Saint Simon" #1 collaborator was "Hoffmann-La Roche" with 7 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 5 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator and "AstraZeneca" with 3 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Diaconesses Croix Saint Simon" are "Ovarian Cancer" (8 trials), "Breast Cancer" (6 trials), "Cancer" (3 trials), "Epithelial Ovarian Cancer" (3 trials) and "Fallopian Tube Cancer" (3 trials). Many other conditions were trialed in "Groupe Hospitalier Diaconesses Croix Saint Simon" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier Diaconesses Croix Saint Simon" are "Drug" (59 trials), "Other" (18 trials), "Procedure" (15 trials), "Device" (9 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (9 trials), "Bevacizumab" (7 trials), "Atezolizumab" (6 trials), "Carboplatin" (5 trials) and "Niraparib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier Diaconesses Croix Saint Simon" are 58 trials for "All" genders, 43 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Groupe Hospitalier Diaconesses Croix Saint Simon". 4 are not yet recruiting, 29 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Groupe Hospitalier Diaconesses Croix Saint Simon, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier Diaconesses Croix Saint Simon, 4 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 17 trials that are defined as “Not Applicable".

Groupe Hospitalier Diaconesses Croix Saint Simon has several departments that took part in Clinical trials: "Hopital Des Diaconesses; Oncologie" - 2 trials